Vetrivelan R, Anaclet C, Fuller PM, Yoshida K, Lu J, Saper CB (2009) Comparison of sleep-wake changes after lesions of two sleep-promoting cell groups in the preoptic region in rats. Neuroscience 2009 Abstracts 277.2/EE14. Society for Neuroscience, Chicago, IL.
Summary: Previous studies have shown that two cell groups within the preoptic region viz., median preoptic nucleus (MnPO) and ventrolateral preoptic nucleus (VLPO) show c-Fos expression during spontaneous sleep. However, while lesions of the VLPO have been shown to cause sleep loss, the effects of MnPO lesions on sleep have not been available to date. We therefore performed cell-body specific lesions of these two nuclei using the toxin orexin-saporin and studied the spontaneous sleep-wake behavior in rats. We found that the animals with more than 70% cell loss in the VLPO (n=15) showed a 31% increase in wakefulness (61.03±1.15% in VLPO-lesioned animals vs 46.53±0.55% in controls, P <0.001) and a concomitant reduction in non rapid eye movement (NREM) sleep and REM sleep. There was also a significant reduction in the average NREM sleep episode duration (120±6.57 Sec Vs 143.04 ± 4.53 sec in control animals, P < 0.01) in rats with VLPO lesions. On the other hand, lesions involving 80-90% cell loss in the MnPO (n=6) produced a moderate 15% increase in wakefulness (53.8±1.09% vs 46.53±0.55% in controls. P<0.001). Although the NREM sleep episode duration was reduced in these animals (126 ± 6.61 Sec vs 143.04 ± 4.53 sec in control animals, P = 0.06), it did not reach statistical significance. The extent of the lesions in the present study was estimated by an individual blind to the experimental conditions and the sleep results. Although specific cell groups (MnPO or VLPO) were carefully targeted, partial damage (10-20%) to the other cell group was often encountered. Nevertheless, our results clearly demonstrate that while the MnPO plays an important role in the regulation of sleep, the VLPO plays a substantially greater role.
Related Products: Orexin-B-SAP (Cat. #IT-20)